Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
…
continue reading
CME credits: 0.25 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/making-the-case-for-dual-ang-2vegf-a-inhibition-anatomical-benefits/18009/ What evidence do we have that blocking Ang-2 and VEGF-A is beneficial for patients? Tune in to hear Dr. Jennifer Lim and Dr. Carl Regillo examine the anatomical and biomarker …
…
continue reading
1
Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2- Early Breast Cancer: A Case-Based Learning Lab
CME credits: 0.25 Valid until: 29-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/improving-outcomes-and-addressing-racial-disparities-in-patients-with-hrher2-early-breast-cancer-a-case-based-learning-lab/16199/ The emergence of the cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) has transformed the treatment landscape for patien…
…
continue reading
CME credits: 1.00 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/cias-effects-on-patients-and-caregivers-what-is-the-personal-and-economic-burden-caused-by-cias/20293/ This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and…
…
continue reading
CME credits: 0.50 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/acc-2024-shasta-2-final-study-results/24408/ This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD t…
…
continue reading
1
Not All Therapy Needs to Be Swallowed or Injected: The Future of Digital Therapeutics to Alleviate the Negative Symptoms of Schizophrenia
CME credits: 1.00 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/not-all-therapy-needs-to-be-swallowed-or-injected-the-future-of-digital-therapeutics-to-alleviate-the-negative-symptoms-of-schizophrenia/20300/ This series of bite-sized episodes will provide important information on cognitive impairment associated w…
…
continue reading
CME credits: 0.50 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/acc-2024-whats-really-new-in-electrophysiology-that-will-change-my-practice/24405/ This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical tr…
…
continue reading
CME credits: 1.00 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/unraveling-the-overlapping-negative-and-cognitive-symptoms-in-schizophrenia/20294/ This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig di…
…
continue reading
CME credits: 1.00 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/program-name/20297/ This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophysiology, diagnosis, and emerging therapies to…
…
continue reading
CME credits: 1.00 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/tools-of-the-trade-measurement-based-care-for-cias/20295/ This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophysiology…
…
continue reading
CME credits: 0.50 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/acc-2024-voyager-pad-part-1/24406/ This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates …
…
continue reading
CME credits: 0.50 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/acc-2024-voyager-pad-part-2/24407/ This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates …
…
continue reading
1
Understanding CIAS: What Does Current Literature Say About the Etiology and Pathophysiology of CIAS?
CME credits: 1.00 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/understanding-cias-what-does-current-literature-say-about-the-etiology-and-pathophysiology-of-cias/20291/ This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey …
…
continue reading
CME credits: 1.00 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/glycines-role-in-driving-the-cognitive-symptoms-of-cias/20292/ This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophysi…
…
continue reading
1
Integration Is the Key to Success: How Will the New SCZ Therapies Fit Into Clinical Treatment Paradigms?
CME credits: 1.00 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/integration-is-the-key-to-success-how-will-the-new-scz-therapies-fit-into-clinical-treatment-paradigms/20299/ This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Har…
…
continue reading
CME credits: 0.50 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/acc-2024-the-pioneer-af-pci-trial/24404/ This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to up…
…
continue reading
CME credits: 1.00 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/challenges-of-integrating-cognitive-remediation-in-cias/20296/ This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophysi…
…
continue reading
1
Staying Current: What Do Recent Clinical Trial Data Say About the New and Emerging Treatment Options for CIAS?
CME credits: 1.00 Valid until: 30-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/staying-current-what-do-recent-clinical-trial-data-say-about-the-new-and-emerging-treatment-options-for-cias/20298/ This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Phil…
…
continue reading
CME credits: 1.00 Valid until: 12-11-2024 Claim your CME credit at https://reachmd.com/programs/cme/experts-on-the-ground-new-data-and-practical-clinical-integration-of-therapies-approved-for-igan/24046/ Expert Nephrologist Pietro Canetta, MD, MS, gives an overview of top abstracts from Kidney Week 2023 and new therapies for IgAN. =…
…
continue reading
1
Overcoming Barriers to Timely Diagnosis and Classification of Interstitial Lung Disease: Considerations for Radiologists
CME credits: 1.00 Valid until: 25-10-2024 Claim your CME credit at https://reachmd.com/programs/cme/overcoming-barriers-to-timely-diagnosis-and-classification-of-interstitial-lung-disease-considerations-for-radiologists/24047/ Learn about making timely and accurate diagnoses of ILD, review radiologic patterns, and discuss the importance of multidis…
…
continue reading
CME credits: 1.00 Valid until: 19-11-2024 Claim your CME credit at https://reachmd.com/programs/cme/pulmonary-arterial-hypertension-screening-diagnosis-and-optimizing-management/24048/ Learn how to use guideline recommendations to establish a diagnosis of pulmonary arterial hypertension (PAH), develop evidence-based individualized treatment plans, …
…
continue reading
1
Leading the Charge on Obesity Management: The Endocrinologist’s Role in Empowering Community Providers to Join the Fight
CME credits: 1.50 Valid until: 26-07-2024 Claim your CME credit at https://reachmd.com/programs/cme/leading-the-charge-on-obesity-management-the-endocrinologists-role-in-empowering-community-providers-to-join-the-fight/18078/ Gain experts’ insights and tools for endocrinology specialists to use to support and empower community-based colleagues in s…
…
continue reading
CME credits: 0.75 Valid until: 26-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/analyzing-key-data-from-lag-3-combinations-in-the-treatment-of-metastatic-melanoma/24364/ This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with metas…
…
continue reading
CME credits: 0.75 Valid until: 26-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/first-line-treatment-of-metastatic-melanoma-after-adjuvant-anti-pd-1/24366/ This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with metastatic melanoma…
…
continue reading
CME credits: 0.75 Valid until: 26-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/what-dermatologists-surgeons-need-to-know-adjuvant-treatment-for-resectable-stage-ii-melanoma/24378/ This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may ben…
…
continue reading
CME credits: 0.75 Valid until: 26-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/future-directions-targeting-lag-3-in-melanoma-treatment/24369/ This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with metastatic melanoma who can bene…
…
continue reading
1
Optimizing Therapeutic Selection for a Patient With Newly Diagnosed BRAF V600e-Mutated Metastatic Melanoma
CME credits: 0.75 Valid until: 26-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/optimizing-therapeutic-selection-for-a-patient-with-newly-diagnosed-braf-v600e-mutated-metastatic-melanoma/24365/ This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to iden…
…
continue reading
1
Patient Case: Tailoring First-Line Treatment for a Patient With Metastatic Melanoma and Impaired Performance Status
CME credits: 0.75 Valid until: 26-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/patient-case-tailoring-first-line-treatment-for-a-patient-with-metastatic-melanoma-and-impaired-performance-status/24368/ This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim…
…
continue reading
1
Navigating Treatment-Related Adverse Effects in LAG-3 Combination ICI Therapy for Metastatic Melanoma
CME credits: 0.75 Valid until: 26-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/navigating-treatment-related-adverse-effects-in-lag-3-combination-ici-therapy-for-metastatic-melanoma/24367/ This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify …
…
continue reading
CME credits: 0.75 Valid until: 26-04-2025 Claim your CME credit at https://reachmd.com/programs/cme/unlocking-synergy-exploring-the-interaction-between-lag-3-and-other-immune-checkpoints/24363/ This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with m…
…
continue reading